Skip to content

Medsurg Percutaneous Transhepatic Cholangiogram

by Medsurg Industries, Inc.

510(k) K854297

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESD Substantially Equivalent — Deferred · Traditional NumberK854297 Date26 Nov 1985ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KNW
Device Class
Class II
Regulation
21 CFR Part 876.1075
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESD Substantially Equivalent — Deferred

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Medsurg Percutaneous Transhepatic Cholangiogram is a diagnostic imaging device used to visualize the biliary tree via radiographic contrast. It is classified under the nomenclature for cholangiography, enabling visualization of bile ducts, gallbladder, and pancreatic ducts through percutaneous needle insertion into the liver.

This device is supplied as a single-use diagnostic tool, regulated under FDA 510(k) clearance (K854297) and classified under product code KNW. It is intended for use in radiology settings, requiring sterile technique and proper handling to ensure accurate imaging of biliary structures. Storage and usage follow standard radiographic safety protocols.

Other devices from Medsurg Industries, Inc.

See all devices from Medsurg Industries, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Medsurg Percutaneous Transhepatic Cholangiogram, and how does it work in a clinical setting?

    The Medsurg Percutaneous Transhepatic Cholangiogram is designed to visualize the biliary tree—including bile ducts, the gallbladder, and pancreatic ducts—using radiographic contrast. It works by inserting a needle percutaneously into the liver, allowing contrast media to be injected so that X-ray imaging can clearly depict the anatomy and any potential obstructions or abnormalities within these structures. This aids in diagnosing conditions like bile duct blockages or gallbladder disease.

  • Is this device intended for repeated use, or is it meant to be used only once per procedure?

    This device is explicitly labeled as a single-use tool. After insertion and imaging, it should not be reused, as single-use medical devices are designed for one-time clinical application to ensure patient safety and sterility. Discard it after use according to standard medical waste protocols.

  • What storage requirements should be followed for the Medsurg Percutaneous Transhepatic Cholangiogram before use?

    The device must be stored following standard radiographic safety protocols, which typically include keeping it in a clean, dry environment away from direct sunlight or extreme temperatures. Since it is single-use and sterile upon packaging, ensure the packaging remains intact until immediately before use to maintain sterility. Avoid exposure to moisture or contamination.

  • How was the regulatory approval process for this device structured, and which committee was involved?

    The Medsurg Percutaneous Transhepatic Cholangiogram received FDA 510(k) clearance under the traditional review pathway, filed on October 25, 1985, and approved on November 26, 1985. The review was conducted by the Gastroenterology and Urology (GU) Advisory Committee, reflecting its relevance to both specialties due to its application in biliary and pancreatic duct imaging.